Perigon Wealth Management LLC Increases Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Perigon Wealth Management LLC raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,680 shares of the pharmacy operator’s stock after purchasing an additional 852 shares during the period. Perigon Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $305,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of WBA. EverSource Wealth Advisors LLC boosted its holdings in shares of Walgreens Boots Alliance by 308.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares in the last quarter. Highlander Capital Management LLC acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at $26,000. Venturi Wealth Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 981 shares in the last quarter. FinTrust Capital Advisors LLC boosted its holdings in shares of Walgreens Boots Alliance by 2,314.5% in the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,273 shares in the last quarter. Finally, Rocky Mountain Advisers LLC acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at $30,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Down 0.1 %

WBA stock opened at $17.64 on Wednesday. Walgreens Boots Alliance, Inc. has a one year low of $17.53 and a one year high of $36.14. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The company has a fifty day moving average of $20.70 and a 200-day moving average of $22.02.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.16 EPS. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Valerie B. Jarrett bought 4,456 shares of the company’s stock in a transaction on Monday, January 29th. The stock was purchased at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the acquisition, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Valerie B. Jarrett purchased 4,456 shares of the firm’s stock in a transaction on Monday, January 29th. The shares were bought at an average cost of $22.44 per share, with a total value of $99,992.64. Following the purchase, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The disclosure for this purchase can be found here. In the last three months, insiders acquired 13,456 shares of company stock worth $270,423. 17.40% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. HSBC reiterated a “reduce” rating and set a $20.00 price target (down previously from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Monday, April 1st. Finally, Barclays assumed coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price target for the company. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus target price of $24.36.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.